Liu Zheng, Hao Zheng, Hu Si, Zhao Yeyu, Li Meihua
Department of Neurosurgery, the First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China.
Medicine (Baltimore). 2019 May;98(19):e15533. doi: 10.1097/MD.0000000000015533.
Posterior fossa decompression (PFD) is the standard procedure for the treatment of Chiari malformation type I (CMI). Although most patients have satisfactory surgical outcomes, some show no improvement or even a worsening of symptoms. Patient selection is thought to account for these different surgical outcomes. Our aim was to evaluate the predictive value of the preoperative posterior cranial fossa (PCF) morphology on the efficacy of PFD.Data from 39 CMI patients with CMI-related symptoms who underwent occipital foramen enlargement + C-1 laminectomy + enlarged duraplasty were retrospectively collected from January 2011 to May 2018. The patients were divided into improved and unimproved groups according to the modified Chicago Chiari Outcome Scale. Demographic information and clinical history, including preoperative comorbidities and clinical manifestations, were recorded for the 2 groups and compared. PCF morphology was assessed based on 13 linear, 8 angular, 4 areal parameters and 4 ratios related to these liner and areal parameters. The data were then analyzed statistically.Of the 39 patients with CMI, 24 showed improvement after PFD (61.5%), whereas the remaining 15 patients showed no improvement (38.5%). The preoperative symptoms lasted 1 to 240 months, with a median of 24 months. The follow-up period ranged from 2 to 82 months, with a median of 27 months. The improved and unimproved groups differed significantly with regard to upper limb numbness (OR = 10, P = .02) and upper limb weakness (OR = 4.86, P = .02). The 2 groups did not differ significantly with regard to any morphological parameters such as tonsillar descent, syrinx size.Preoperative upper limb numbness and upper limb weakness are unfavorable factors that influence the outcome of PFD in patients with CMI. However, the morphology of PCF cannot predict the response to PFD in patients with CMI.
后颅窝减压术(PFD)是治疗I型Chiari畸形(CMI)的标准手术方法。尽管大多数患者手术效果满意,但仍有部分患者症状无改善甚至加重。患者选择被认为是导致这些不同手术结果的原因。我们的目的是评估术前颅后窝(PCF)形态对PFD疗效的预测价值。
回顾性收集2011年1月至2018年5月期间39例有CMI相关症状并接受枕骨大孔扩大术+C1椎板切除术+扩大硬脑膜成形术的CMI患者的数据。根据改良的芝加哥Chiari疗效量表将患者分为改善组和未改善组。记录两组患者的人口统计学信息和临床病史,包括术前合并症和临床表现,并进行比较。基于13个线性参数、8个角度参数、4个面积参数以及与这些线性和面积参数相关的4个比率对PCF形态进行评估。然后对数据进行统计学分析。
在39例CMI患者中,24例(61.5%)PFD术后症状改善,其余15例(38.5%)无改善。术前症状持续1至240个月,中位数为24个月。随访时间为2至82个月,中位数为27个月。改善组和未改善组在上肢麻木(OR = 10,P = 0.02)和上肢无力(OR = 4.86,P = 0.02)方面差异有统计学意义。两组在扁桃体下移、空洞大小等任何形态学参数方面差异均无统计学意义。
术前上肢麻木和上肢无力是影响CMI患者PFD手术效果的不利因素。然而,PCF形态不能预测CMI患者对PFD的反应。